PS

Pawan Soni

Active Director Director DIN 07387948
DIN 07387948 First appointment Jan 2016 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jan 2016
Shareholding value Locked Premium profile

About Pawan Soni

Data last updated:

Pawan Soni has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Jaschem Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07387948
Primary Designation Director
First Appointment 27 Jan 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Director27 Jan 20162016Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jaschem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pawan Soni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Soni

Pawan Soni has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Jaschem Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Pawan Soni is associated with 1 company as Director.

Pawan Soni has expertise in General Business.

Pawan Soni has 10 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available